Safety and efficacy of generic daclatasvir-sofosbuvir as a pan genotypic regimen for HCV-infected patients in Bandung, Indonesia

被引：0
|
作者：
Bestari, Muhammad Begawan [1 ]
Nugraha, Eka Surya [1 ]
Abdurachman, Siti Aminah [1 ]
机构：
[1] Univ Padjadjaran, Hasan Sadikin Gen Hosp, Dept Internal Med GI Hepatol, Bandung, Indonesia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 33卷
关键词：
hepatitis C; pan genotypic; treatment; sofosbuvir; daclatasvir;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OE-0189 (P
引用
收藏
页码：443 / 443
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
    Pol, Stanislas
    Bourliere, Marc
    Lucier, Sandy
    Hezode, Christophe
    Dorival, Celine
    Larrey, Dominique
    Bronowicki, Jean-Pierre
    Ledinghen, Victor D. E.
    Zoulim, Fabien
    Tran, Albert
    Metivier, Sophie
    Zarski, Jean-Pierre
    Samuel, Didier
    Guyader, Dominique
    Marcellin, Patrick
    Minello, Anne
    Alric, Laurent
    Thabut, Dominique
    Chazouilleres, Olivier
    Riachi, Ghassan
    Bourcier, Valerie
    Mathurin, Philippe
    Loustaud-Ratti, Veronique
    D'Alteroche, Louis
    Fouchard-Hubert, Isabelle
    Habersetzer, Francois
    Causse, Xavier
    Geist, Claire
    Rosa, Isabelle
    Gournay, Jerome
    Saillard, Eric
    Billaud, Eric
    Petrov-Sanchez, Ventzislava
    Diallo, Alpha
    Fontaine, Helene
    Carrat, Fabrice
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : 39 - 47
  • [2] DACLATASVIR PLUS SOFOSBUVIR FOR CHRONIC HCV-INFECTED KIDNEY TRANSPLANT RECIPIENTS - A PILOT STUDY OF EFFICACY AND SAFETY
    Duerr, M.
    Staeck, O.
    Khadzhynov, D.
    Schrezenmeier, E.
    Lehner, L.
    Budde, K.
    Halleck, F.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 20 - 20
  • [3] Efficacy and Safety of Generic Sofosbuvir Plus Daclatasvir and Sofosbuvir/Velpatasvir in HCV Genotype 3-Infected Patients: Real-World Outcomes From Pakistan
    Mushtaq, Saima
    Akhter, Tayyab Saeed
    Khan, Amjad
    Sohail, Aamir
    Khan, Arshad
    Manzoor, Sobia
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [4] SAFETY AND EFFICACY OF THE COMBINATION DACLATASVIR-SOFOSBUVIR IN HCV GENOTYPE 1-MONO-INFECTED PATIENTS FROM THE FRENCH OBSERVATIONAL COHORT ANRS CO22 HEPATHER
    Pol, S.
    Bourliere, M.
    Lucier, S.
    De Ledinghen, V.
    Zoulim, F.
    Dorival-Mouly, C.
    Metivier, S.
    Larrey, D.
    Tran, A.
    Hezode, C.
    Bronowicki, J. -P.
    Samuel, D.
    Marcellin, P.
    Zarski, J. -P.
    Minello, A.
    Alric, L.
    Trinchet, J. -C.
    Nahon, P.
    Guyader, D.
    Chazouilleres, O.
    Riachi, G.
    Loustaud-Ratti, V.
    Causse, X.
    Mathurin, P.
    Hubert-Fouchard, I.
    Rosa, I.
    Benhamou, Y.
    Gournay, J.
    Raabe, J. -J.
    Raffi, F.
    Petrov-Sanchez, V.
    Diallo, A.
    Fontaine, H.
    Carrat, F.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S258 - S259
  • [5] Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials
    Brown, Ashley
    Welzel, Tania M.
    Conway, Brian
    Negro, Francesco
    Brau, Norbert
    Grebely, Jason
    Puoti, Massimo
    Aghemo, Alessio
    Kleine, Henning
    Pugatch, David
    Mensa, Federico J.
    Chen, Yaozhu J.
    Lei, Yang
    Lawitz, Eric
    Asselah, Tarik
    LIVER INTERNATIONAL, 2020, 40 (04) : 778 - 786
  • [6] EFFICACY OF SOFOSBUVIR AND DACLATASVIR IN HIV/HCV CO-INFECTED PATIENTS WITH ADVANCED FIBROSIS
    Antonini, T. M.
    Bedoya, J. Ursic
    Teicher, E.
    Coilly, A.
    de Martin, E.
    Roque-Afonso, A. -M.
    Quertainmont, Y.
    Goujard, C.
    Delfraissy, J. -F.
    Vittecoq, D.
    Samuel, D.
    Duclos-Vallee, J. -C.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S651 - S651
  • [7] An Integrated Safety and Efficacy Analysis of Sofosbuvir-Based Regimens in HCV-infected Patients with Hereditary Bleeding Disorders
    Stedman, Catherine
    Workowski, Kimberly
    Yang, Jenny C.
    Natha, Macky
    Abramov, Frida
    Brainard, Diana M.
    Mchutchison, John G.
    Balba, Gayle P.
    Gane, Edward J.
    Reddy, K. Rajender
    HAEMOPHILIA, 2016, 22 : 22 - 22
  • [8] Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
    Mohamed, Inas E. L-Khedr
    EL-Saeed, Kadry Mohamed
    Al-Sadik, Mahmoud Hassan
    Anwar, Christina Alphonse
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [9] Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
    Inas E L-Khedr Mohamed
    Kadry Mohamed EL-Saeed
    Mahmoud Hassan Al-Sadik
    Christina Alphonse Anwar
    Egyptian Liver Journal, 11
  • [10] Exposure-Response Analysis for Efficacy of Daclatasvir, Asunaprevir, and Beclabuvir Combinations in HCV-Infected Patients
    Ueno, T.
    Osawa, M.
    Shiozaki, T.
    Green, M.
    Garimella, T.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (07): : 903 - 913
12345